Zobrazeno 1 - 4
of 4
pro vyhledávání: '"76"'
Autor:
Murilo Lopes de Mello, Daniele Evangelista-Leite, Bruno Shouta Yamashita, Ethel Zimberg Chehter, Breno Affonso Madaloso, Lucas Polito Verdasca, Francesco Enrico Aloise, Renan Murata Hayashi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 7, p e0253695 (2021)
PLoS ONE, Vol 16, Iss 7, p e0253695 (2021)
Immunoproliferative Small Intestinal Disease (IPSID) is a disease characterized by extra-nodal marginal zone B-cell lymphoma with villous atrophy in the small intestine, causing chronic intermittent non-bloody diarrhea. Although originally associated
Autor:
London L.P.J. Ooi, Brian K. P. Goh, Alexander Y. F. Chung, Kai Siang Chan, Jin Yao Teo, Prema Raj Jeyaraj, Ser Yee Lee, Nandhini Srinivasan, Ye Xin Koh, Ek Khoon Tan, Chung Yip Chan, Pierce K. H. Chow, Peng Chung Cheow
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0240737 (2020)
PLoS ONE
PLoS ONE
Background Venous reconstruction has been recently demonstrated to be safe for tumours with invasion into portal vein and/or superior mesenteric vein. This study aims to compare the patency between various venous reconstructions. Methods This is retr
Autor:
Joel Collins, Ahmed Mohamed, Paula Marlton, Federico Torta, Robert Bird, Markus R. Wenk, Peter Mollee, Thomas Stoll, Hui Jiang, Michelle M. Hill, Kate A. Markey, Jeffrey Molendijk
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0227455 (2020)
PLoS ONE, Vol 15, Iss 1, p e0227455 (2020)
BackgroundMultiple myeloma (MM) is a hematological malignancy characterized by the clonal expansion of malignant plasma cells. Though durable remissions are possible, MM is considered incurable, with relapse occurring in almost all patients. There ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8464c06361094838912a8fd82b0fe024
Autor:
Charles Dumontet, Marion Teisseire, Lionel Karlin, Sandrine Couray-Targe, Delphine Maucort-Boulch
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 5, p e0196596 (2018)
PLoS ONE, Vol 13, Iss 5, p e0196596 (2018)
Background Patients with multiple myeloma included in prospective clinical trials are highly selected and therefore are expected not to be representative of the entire patient population. Additionally recommendations based on literature data and rand